A systematic review and meta-analysis assessing adverse event profile and tolerability of nicergoline

Objective To evaluate the safety profile of nicergoline compared with placebo and other active agents from published randomised controlled trials.Design Systematic review and meta-analysis of nicergoline compared with placebo and other active agents across various indications.Data sources MEDLINE, M...

Full description

Saved in:

Bibliographic Details
Main Authors:	Amit Garg, Jun Xu, Mario Fioravanti, Taku Nakashima
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2014-07-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/4/7/e005090.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Disproportionality analysis of upadacitinib-related adverse events in inflammatory bowel disease using the FDA adverse event reporting system
by: Shiyi Wang, et al.
Published: (2025-02-01)

Safety profiles of IDH inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
by: Ximu Sun, et al.
Published: (2025-02-01)

Adverse childhood experiences and elder abuse victimization nexus: A systematic review and meta-analysis.
by: Kofi Awuviry-Newton, et al.
Published: (2025-01-01)

Association between frailty and hospital-related adverse events in older hospitalised patients: a systematic literature review protocol
by: Jay Banerjee, et al.
Published: (2025-02-01)

Adverse events in the nervous system associated with blinatumomab: a real-world study
by: Wen Gao, et al.
Published: (2025-02-01)

Association of high γ′ fibrinogen levels with adverse events in patients with COVID-19
by: Queen Revollido, et al.
Published: (2025-02-01)

Comparisons of adverse events associated with immune checkpoint inhibitors in the treatment of non-small cell lung cancer: a real-world disproportionality analysis based on the FDA adverse event reporting system
by: Ruichen Gao, et al.
Published: (2025-02-01)

Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database
by: Xi-Feng Wang, et al.
Published: (2025-01-01)

Expanding on Abraxane Safety: Temporal Insights and Future Directions for Adverse Event Analysis [Letter]
by: Yang F, et al.
Published: (2025-02-01)

Analysis of ADR reports of cetuximab based on the FDA adverse event reporting system database
by: Shuai Zhao, et al.
Published: (2025-02-01)

Corrigendum: Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database
by: Xi-Feng Wang, et al.
Published: (2025-02-01)

The Effects of Adverse Events and Associated Costs on Value-Based Care for Metastatic Pancreatic Ductal Adenocarcinoma
by: Prachi Bhatt, et al.
Published: (2024-12-01)

A decade-long overview of adverse events in a tertiary surgical service in South Africa
by: H Wain, et al.
Published: (2024-10-01)

Safety profile of sacituzumab govitecan in patients with breast cancer: A systematic review and meta-analysis
by: Maria Inez Dacoregio, et al.
Published: (2025-02-01)

Risk of adverse cardiovascular events following spinal cord injury in patients with osteoporosis: Real-world evidence
by: Shih-Kai Kao, et al.
Published: (2025-03-01)

T-cell receptor beta variable gene polymorphism predicts immune-related adverse events during checkpoint blockade immunotherapy
by: Linghua Wang, et al.
Published: (2023-08-01)

The effectiveness of hyaluronic acid in reducing adverse effects associated with inhaled hypertonic saline therapy in patients with cystic fibrosis: A systematic review and meta-analysis
by: Sana Arshid, et al.
Published: (2023-10-01)

Exploration of the optimal deep learning model for english-Japanese machine translation of medical device adverse event terminology
by: Ayako Yagahara, et al.
Published: (2025-02-01)

Methods for identifying adverse drug reactions in primary care: A systematic review.
by: Vera Logan, et al.
Published: (2025-01-01)

High risk for life-threatening adverse events of fluoroquinolones in young adults: a large German population-based cohort study
by: Julia Wicherski, et al.
Published: (2025-02-01)

Multimorbidity in Atherosclerotic Cardiovascular Disease and Its Associations With Adverse Cardiovascular Events and Healthcare Costs: A Real-World Evidence Study
by: Dingwei Dai, et al.
Published: (2024-03-01)

Performance of artificial intelligence on cervical vertebral maturation assessment: a systematic review and meta-analysis
by: Termeh Sarrafan Sadeghi, et al.
Published: (2025-02-01)

Assessing Soil Tolerance Limit for Two Soil Orders Surrounding Sulaimani City
by: Marwa Abubakr Ahmed, et al.
Published: (2019-12-01)

Pesticide Tolerances and Exemptions
by: Mark A. Mossler, et al.
Published: (2006-04-01)

Pesticide Tolerances and Exemptions
by: Mark A. Mossler, et al.
Published: (2006-04-01)

Tolerance for inequality in Thailand
by: Wannaphong Durongkaveroj
Published: (2025-12-01)

The effect of magnesium supplementation on serum concentration of lipid profile: an updated systematic review and dose-response meta-analysis on randomized controlled trials
by: Mitra Hariri, et al.
Published: (2025-02-01)

Impact of statin use on major adverse cardiovascular events in patients with normal stress myocardial perfusion imaging and elevated coronary artery calcium score
by: Yi Hui To, et al.
Published: (2023-02-01)

Major adverse cardiovascular events among Black and White Veterans receiving androgen deprivation therapy for prostate cancer: a retrospective cohort study
by: Alexander R. Lucas, et al.
Published: (2025-02-01)

Efficacy of electroacupuncture for insomnia in cancer patients: a systematic review and meta-analysis
by: Xiaodong Liu, et al.
Published: (2025-02-01)

Sex differences of fall-risk-increasing drugs in the middle-aged and elderly: a descriptive, cross-sectional study of FDA adverse event reporting system
by: Ying Zhao, et al.
Published: (2024-11-01)

Symptoms and coronary risk factors predictive of adverse cardiac events in chest pain patients in an Asian emergency department: the need for a local prediction score
by: Ziwei Lin, et al.
Published: (2024-07-01)

Post-marketing safety surveillance for the recombinant zoster vaccine (Shingrix), vaccine adverse event reporting system, United States, October 2017–April 2024
by: Yamin Shu, et al.
Published: (2025-02-01)

Comparative efficacy of clopidogrel-aspirin combination therapy versus aspirin monotherapy in preventing recurrent events in transient ischemic attack and minor stroke: a systematic review and meta-analysis
by: Ahmad Mujtaba Bhutto, et al.
Published: (2025-02-01)

Factors influencing sleep disorders in perimenopausal women: a systematic review and meta-analysis
by: Weisi Zeng, et al.
Published: (2025-02-01)

Prevalence and Incidence of Injury during Olympic-style Shooting Events: A Systematic Review
by: Mica R. Harr, et al.
Published: (2021-10-01)

Resilient religion: Resilience and heartbreaking adversity
by: N. Niemandt
Published: (2024-06-01)

Balloon dilation for the treatment of male urethral strictures: a systematic review and meta-analysis
by: Tianyu Cai, et al.
Published: (2024-02-01)

Author Correction: Sex differences of fall-risk-increasing drugs in the middle-aged and elderly: a descriptive, cross-sectional study of FDA adverse event reporting system
by: Ying Zhao, et al.
Published: (2025-02-01)

Efficacy of acupuncture in treating chemotherapy-related cognitive impairment in breast cancer patients: A systematic review and meta-analysis protocol.
by: Lishi Liu, et al.
Published: (2025-01-01)